Alpha 2.0
Login Register
» Authors » Giorgio DAnnibale

Giorgio DAnnibale

Explore the profile of Giorgio DAnnibale including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 3
Followers 0
Related Specialties
Oncology
General Surgery
Top 10 Co-Authors
Fabio Pacelli
Francesco Santullo
Andrea Di Giorgio
Federica Ferracci
Luca DAgostino
Carlo Abatini
Claudio Lodoli
Cecilia Orsini
Matteo Aulicino
Miriam Attalla El Halabieh
Published In
Cancers (Basel)
Langenbecks Arch Surg
Minerva Surg
Affiliations
Soon will be listed here.
Recent Articles
1.
Predictive Factors for the Discontinuation of Pressurized Intraperitoneal Aerosol Chemotherapy: Enhancing Patient Selection to Improve Oncological Outcomes-A Single-Center Experience
Aulicino M, Santullo F, Orsini C, DAgostino L, Hubner M, Texeira-Farinha H, et al.
Cancers (Basel) . 2025 Jan; 17(2). PMID: 39858047
: Since 2011, Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) has emerged as a promising treatment option for patients with peritoneal surface malignancies (PSM) who are not eligible for cytoreductive surgery (CRS)....
2.
Efficacy and Insights from an Extensive Series of Cytoreductive Surgery for Peritoneal Neoplasms: A High-Volume Single-Center Experience
Aulicino M, Santullo F, DAnnibale G, Abatini C, Attalla El Halabieh M, Orsini C, et al.
Cancers (Basel) . 2025 Jan; 16(24. PMID: 39766128
Advances in cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) and pressurized intraperitoneal aerosol chemotherapy (PIPAC) have improved outcomes for selected patients with peritoneal surface malignancies (PSMs). This retrospective...
3.
How to Implement Pressurized Intraperitoneal Aerosol Chemotherapy into a National Health System Scenario: A Single-Center Retrospective Analysis of Costs and Economic Sustainability at a High-Volume Italian Hospital
Aulicino M, Orsini C, DAnnibale G, Barberis L, Catania P, Abatini C, et al.
Cancers (Basel) . 2024 Aug; 16(15). PMID: 39123365
PIPAC is a new surgical procedure and a viable treatment option for PSM patients, due to promising therapeutic outcomes, minimal invasiveness, limited surgical morbidity, and systemic toxicity side effects. However,...
4.
Nonoperative management and local excision after neoadjuvant chemoradiation therapy for rectal cancer
Rizzo G, Amodio L, DAnnibale G, Marzi F, Quero G, Menghi R, et al.
Minerva Surg . 2024 Jul; 79(4):470-480. PMID: 38953759
Locally advanced extraperitoneal rectal cancer represents a significant clinical challenge, and currently, the standard treatment is based on neoadjuvant chemoradiation therapy (CRT) followed by radical surgical resection with total mesorectal...
5.
Efficacy of Cytoreductive Surgery (CRS) + HIPEC in Gastric Cancer with Peritoneal Metastasis: Systematic Review and Meta-Analysis
Langellotti L, Fiorillo C, DAnnibale G, Panza E, Pacelli F, Alfieri S, et al.
Cancers (Basel) . 2024 May; 16(10). PMID: 38792007
Background: Peritoneal carcinomatosis is one of deadliest metastatic patterns of gastric cancer, being associated with a median overall survival (OS) of 4 months. Up to now, palliative systemic chemotherapy (pSC)...
6.
Gastric cancer with peritoneal metastases: a single center outline and comparison of different surgical and intraperitoneal treatments
Santullo F, Ferracci F, Abatini C, Attalla El Halabieh M, Lodoli C, DAnnibale G, et al.
Langenbecks Arch Surg . 2023 Nov; 408(1):437. PMID: 37973620
Introduction: Gastric cancer with peritoneal metastasis (GCPM) has an unfavourable prognosis. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CRS + HIPEC) and pressurized intraperitoneal aerosol chemotherapy (PIPAC) are promising treatment options...